Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation.

Uwe Klaus Zettl,Paulus Stefan Rommer,Orhan Aktas,Torsten Wagner,Joachim Richter, Patrick Oschmann, Lukas Cepek, Birte Elias-Hamp,Klaus Gehring,Andrew Chan,Michael Hecker

Expert review of clinical immunology（2023）

引用 0|浏览2

暂无评分

摘要

IFN beta-1a sc paved the way to effective immunomodulatory treatment of MS, enabled meaningful insights into the disease process, and remains a valid therapeutic option in selected vulnerable MS patient groups.

查看译文

关键词

multiple sclerosis,interferon

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要